PBGD Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of PBGD monoclonal antibodies for investigating porphobilinogen deaminase (PBGD) function and biological roles. PBGD Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Porphobilinogen deaminase is a crucial enzyme in the heme biosynthesis pathway, catalyzing the conversion of porphobilinogen to hydroxymethylbilane. PBGD plays a significant role in the production of heme, which is essential for various biological processes, including oxygen transport and electron transfer in cellular respiration. Understanding PBGD function is vital for elucidating disorders related to heme metabolism, such as acute intermittent porphyria. Research into PBGD has revealed its importance in maintaining proper heme levels across different tissue types. Investigating PBGD expression patterns can provide insights into metabolic disorders and potential therapeutic approaches. PBGD research continues to uncover new aspects of heme metabolism regulation and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of PBGD and its role in human health and disease.